| Dr Imad Abumeri, MD | |
|
2001 F St, Bakersfield, CA 93301-4237 | |
| (661) 404-4731 | |
| (661) 404-4732 |
| Full Name | Dr Imad Abumeri |
|---|---|
| Gender | Male |
| Speciality | Neurosurgery |
| Experience | 37 Years |
| Location | 2001 F St, Bakersfield, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295732980 | NPI | - | NPPES |
| 1295732980 | Medicaid | CA | |
| 35075732 | Other | OH | MEDICAL LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207T00000X | Neurological Surgery | 35075732 (Ohio) | Secondary |
| 207T00000X | Neurological Surgery | C53377 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Antelope Valley Hospital | Lancaster, CA | Hospital |
| Entity Name | Antelope Valley Neuroscience |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114912979 PECOS PAC ID: 0345205944 Enrollment ID: O20041123000496 |
News Archive
ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, is pleased to announce that Mehdi Adineh, Ph.D., scientific director of the imaging core laboratory of the American College of Radiology (ACR), has been named an industry leader by Life Science Leader magazine.
Biomedical engineers at Duke University have developed an automated process that can trace the shapes of active neurons as accurately as human researchers can, but in a fraction of the time.
Tens of thousands of Americans live with a ticking time bomb in their chests. Now, a new University of Michigan study demonstrates that many of them may not need surgery in order to defuse it.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 1 days ago
| Entity Name | Kern Neurosurgical Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659792158 PECOS PAC ID: 7517197510 Enrollment ID: O20140312001170 |
News Archive
ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, is pleased to announce that Mehdi Adineh, Ph.D., scientific director of the imaging core laboratory of the American College of Radiology (ACR), has been named an industry leader by Life Science Leader magazine.
Biomedical engineers at Duke University have developed an automated process that can trace the shapes of active neurons as accurately as human researchers can, but in a fraction of the time.
Tens of thousands of Americans live with a ticking time bomb in their chests. Now, a new University of Michigan study demonstrates that many of them may not need surgery in order to defuse it.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 1 days ago
| Entity Name | Kern County Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376623538 PECOS PAC ID: 4688964521 Enrollment ID: O20160915002690 |
News Archive
ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, is pleased to announce that Mehdi Adineh, Ph.D., scientific director of the imaging core laboratory of the American College of Radiology (ACR), has been named an industry leader by Life Science Leader magazine.
Biomedical engineers at Duke University have developed an automated process that can trace the shapes of active neurons as accurately as human researchers can, but in a fraction of the time.
Tens of thousands of Americans live with a ticking time bomb in their chests. Now, a new University of Michigan study demonstrates that many of them may not need surgery in order to defuse it.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 1 days ago
| Entity Name | Imad Abumeri M D Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326677857 PECOS PAC ID: 8527499136 Enrollment ID: O20200515000761 |
News Archive
ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, is pleased to announce that Mehdi Adineh, Ph.D., scientific director of the imaging core laboratory of the American College of Radiology (ACR), has been named an industry leader by Life Science Leader magazine.
Biomedical engineers at Duke University have developed an automated process that can trace the shapes of active neurons as accurately as human researchers can, but in a fraction of the time.
Tens of thousands of Americans live with a ticking time bomb in their chests. Now, a new University of Michigan study demonstrates that many of them may not need surgery in order to defuse it.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Imad Abumeri, MD Po Box 22134, Bakersfield, CA 93390-2134 Ph: (661) 404-4731 | Dr Imad Abumeri, MD 2001 F St, Bakersfield, CA 93301-4237 Ph: (661) 404-4731 |
News Archive
ACR Image Metrix™, an imaging contract research organization (CRO) located in Philadelphia, Pennsylvania, is pleased to announce that Mehdi Adineh, Ph.D., scientific director of the imaging core laboratory of the American College of Radiology (ACR), has been named an industry leader by Life Science Leader magazine.
Biomedical engineers at Duke University have developed an automated process that can trace the shapes of active neurons as accurately as human researchers can, but in a fraction of the time.
Tens of thousands of Americans live with a ticking time bomb in their chests. Now, a new University of Michigan study demonstrates that many of them may not need surgery in order to defuse it.
ZIOPHARM Oncology, Inc. today announced that the first patient has been dosed in a Phase 1 clinical study of ZIN ATI-001, a novel DNA-based therapeutic candidate, in patients with advanced melanoma.
› Verified 1 days ago
Dr. Philip Rosenthal, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 2323 16th St Ste 407, Bakersfield, CA 93301 Phone: 661-741-0924 Fax: 661-741-0930 | |
Dr. Benjamin Jon Serxner, M.D. Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3838 San Dimas St Ste A140, Bakersfield, CA 93301 Phone: 661-632-7126 Fax: 661-324-3606 | |
Olusegun B Leramo, M.D. Neurological Surgery Medicare: Medicare Enrolled Practice Location: 2601 Oswell St, Suite 101, Bakersfield, CA 93306 Phone: 661-872-9999 Fax: 661-872-1915 | |
Dr. William Joseph Meyer, MD Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 2201 Mt Vernon Ave, Ste 211, Bakersfield, CA 93306 Phone: 661-872-7000 Fax: 661-872-0499 | |
James Scott Johnston, M.D. Neurological Surgery Medicare: Not Enrolled in Medicare Practice Location: 301 Brundage Ln, Bakersfield, CA 93304 Phone: 661-323-6086 Fax: 661-324-6301 | |
Dr. Timothy Mitchell Wiebe, MD, FAANS Neurological Surgery Medicare: Accepting Medicare Assignments Practice Location: 3545 San Dimas St, Bakersfield, CA 93301 Phone: 661-323-1947 Fax: 661-323-1904 |